Abiraterone steroid formulation

  • US 10,292,990 B2
  • Filed: 11/07/2016
  • Issued: 05/21/2019
  • Est. Priority Date: 09/27/2013
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating prostate cancer comprising administering methylprednisolone and a daily dose of between 400 and 600 mg of abiraterone acetate, wherein the abiraterone acetate is in the form of a tablet or a capsule and has a median particle size of 100 nm to 1000 nm on a volume average basis.

View all claims

    Thank you for your feedback